Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Omar Raslan"'
Autor:
Omar Raslan, Alejandro Garcia-Horton
Publikováno v:
Expert opinion on pharmacotherapy. 23(8)
Acute myeloid leukemia (AML) predominantly affects elderly population. This poses challenges in management, as patients are frequently not candidates for intensive therapy given comorbidities or frailty. Currently, azacitidine (AZA), either as monoth
Autor:
Brittany Salter, Omar Raslan, Suzanne Demczuk, Brian Leber, Alejandro Garcia-Horton, Irwin Walker, Tobias Berg, Darci Butcher, Kylie L. Lepic, Elizabeth McCready, Parveen Wasi, Dina Khalaf
Publikováno v:
Blood. 140:12916-12917
Publikováno v:
Neuro-Oncology. 24:vii61-vii61
The recurrence rate for glioblastomas is essentially 100% and median overall survival (OS) for recurrent glioblastoma patients is usually poor, approximately 6-8 months from first recurrence. There is an unmet need in recurrent glioblastomas for nove
Publikováno v:
Journal of Medical Cases
Sickle cell disease (SCD) is one of the most commonly inherited conditions on the Arabian Peninsula. We report a case of a 17-year-old boy, who had previously been diagnosed with SCD and glucose-6-phosphate dehydrogenase (G6PD) deficiency and recentl
Autor:
Cyrus C. Hsia, Omar Raslan
Publikováno v:
Blood. 137(11)
Publikováno v:
Saudi Journal of Internal Medicine. 3:35-41
We report a case of a 30-year-old male presented with acute pancreatitis after a period of diclofenac (Voltaren®) use. Other causes of pancreatitis were ruled out by thorough history, physical examination, and investigations. The patient was admitte
Publikováno v:
Journal of the Saudi Heart Association. (4):265-271
We report the case of a 40-year-old patient with incessant supraventricular tachycardia (SVT). As this SVT was resistant to medical therapy and was complicated by severe LV dysfunction and cardiogenic shock, the patient was referred for EPS (electrop